日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Atezolizumab + Chemotherapy for Advanced Non-Small Cell Lung Cancer in Japanese Clinical Practice (J-TAIL-2)

阿特珠单抗联合化疗治疗日本临床实践中的晚期非小细胞肺癌（J-TAIL-2）

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.70242
Yoshioka, Hiroshige; Nishio, Makoto; Ohashi, Kadoaki; Osoegawa, Atsushi; Kikuchi, Eiki; Kimura, Hideharu; Goto, Yasushi; Shimizu, Junichi; Miyauchi, Eisaku; Yoshino, Ichiro; Misumi, Toshihiro; Watanabe, Yasutaka; Hata, Akito; Kisohara, Akira; Kuyama, Shoichi; Yamaguchi, Masafumi; Miwa, Asako; Iwasawa, Shunichiro; Tanaka, Misa; Gemma, Akihiko
肺癌
肿瘤
肿瘤免疫
IL-2
细胞生物学
发表日期：2026
文献求助 收藏

Potential Immune Microenvironment Biomarkers in SCLC: J-TAIL-2 Observational Study

小细胞肺癌中潜在的免疫微环境生物标志物：J-TAIL-2 观察性研究

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2025.100926
Shirasawa, Masayuki; Nishio, Makoto; Ohashi, Kadoaki; Osoegawa, Atsushi; Kikuchi, Eiki; Kimura, Hideharu; Goto, Yasushi; Shimizu, Junichi; Miyauchi, Eisaku; Yoshioka, Hiroshige; Yoshino, Ichiro; Misumi, Toshihiro; Yatabe, Yasushi; Yoshida, Tatsuya; Kashima, Jumpei; Oki, Masahide; Ashimura, Hisao; Kobayashi, Yuki; Tanaka, Misa; Gemma, Akihiko
肺癌
肿瘤
肿瘤免疫
IL-2
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

Clinical Characteristics and Spatial Transcriptome Analysis of Non-Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG Study

早期阿来替尼耐药非小细胞肺癌的临床特征和空间转录组分析：一项回顾性OLCSG研究

期刊:Cancer Research Communications
影响因子:3.3
doi:10.1158/2767-9764.CRC-25-0545
Kuribayashi, Tadahiro; Makimoto, Go; Ohashi, Kadoaki; Tomida, Shuta; Inoue, Hirofumi; Yokoyama, Toshihide; Kuyama, Shoichi; Kato, Yuka; Kudo, Kenichiro; Horita, Naokatsu; Kayatani, Hiroe; Inoue, Masaaki; Sugimoto, Keisuke; Ninomiya, Kiichiro; Maeda, Yoshinobu; Togashi, Yosuke; Hotta, Katsuyuki
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

High Antigenicity for T(reg) Cells Confers Resistance to PD-1 Blockade Therapy via High PD-1 Expression in T(reg) Cells

T(reg)细胞的高抗原性通过T(reg)细胞中高PD-1表达赋予其对PD-1阻断疗法的耐药性

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.70029
Matsuura, Hiroaki; Ishino, Takamasa; Ninomiya, Toshifumi; Ninomiya, Kiichiro; Tachibana, Kota; Honobe-Tabuchi, Akiko; Muto, Yoshinori; Inozume, Takashi; Ueda, Youki; Ohashi, Kadoaki; Maeda, Yoshinobu; Nagasaki, Joji; Togashi, Yosuke
细胞生物学
PD-1
发表日期：2025
文献求助 收藏

Plasma S100A8/A9 level predicts response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer

血浆S100A8/A9水平可预测晚期非小细胞肺癌患者对免疫检查点抑制剂的反应

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-87232-z
Kuribayashi, Tadahiro; Kinoshita, Rie; Ninomiya, Kiichiro; Makimoto, Go; Kubo, Toshio; Rai, Kammei; Ichihara, Eiki; Hotta, Katsuyuki; Tabata, Masahiro; Maeda, Yoshinobu; Kiura, Katsuyuki; Toyooka, Shinichi; Sakaguchi, Masakiyo; Ohashi, Kadoaki
肺癌
肿瘤
S100A8
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

J-TAIL-2: A Prospective, Observational Study of Atezolizumab Combined With Carboplatin and Etoposide in Patients With Extensive-Stage SCLC in Japan

J-TAIL-2：一项在日本开展的前瞻性观察研究，评估阿特珠单抗联合卡铂和依托泊苷治疗广泛期小细胞肺癌患者的疗效

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2024.100783
Miyauchi, Eisaku; Nishio, Makoto; Ohashi, Kadoaki; Osoegawa, Atsushi; Kikuchi, Eiki; Kimura, Hideharu; Goto, Yasushi; Shimizu, Junichi; Yoshioka, Hiroshige; Yoshino, Ichiro; Misumi, Toshihiro; Katakami, Nobuyuki; Oki, Masahide; Kijima, Takashi; Chikamori, Kenichi; Nishino, Kazumi; Kobayashi, Yuki; Miwa, Asako; Tanaka, Misa; Gemma, Akihiko
肺癌
肿瘤
肿瘤免疫
IL-2
细胞生物学
发表日期：2025
文献求助 收藏

Asian Subgroup Analysis of Patients in the Phase 2 DeLLphi-301 Study of Tarlatamab for Previously Treated Small Cell Lung Cancer

既往接受过治疗的小细胞肺癌患者接受 Tarlatamab 治疗的 II 期 DeLLphi-301 研究中亚洲亚组分析

期刊:Oncology and Therapy
影响因子:3.2
doi:10.1007/s40487-025-00372-0
Ahn, Myung-Ju; Cho, Byoung Chul; Ohashi, Kadoaki; Izumi, Hiroki; Lee, Jong-Seok; Han, Ji-Youn; Chiang, Chi-Lu; Huang, Shuang; Hamidi, Ali; Mukherjee, Sujoy; Xu, Krista Lin; Akamatsu, Hiraoki
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Single-lung Transplant in a Patient with Mycobacterium avium Pulmonary Disease Successfully Treated with Amikacin Liposome Inhalation Suspension

一例患有鸟分枝杆菌肺病的患者接受单肺移植后，使用阿米卡星脂质体吸入混悬液治疗成功

期刊:Internal Medicine
影响因子:1.1
doi:10.2169/internalmedicine.3854-24
Ozeki, Taichi; Higo, Hisao; Omori, Hiroki; Mori, Shunta; Tanaka, Shin; Makimoto, Go; Ninomiya, Kiichiro; Taniguchi, Akihiko; Fujii, Masanori; Miyoshi, Kentaro; Rai, Kammei; Ichihara, Eiki; Ohashi, Kadoaki; Sugimoto, Seiichiro; Hotta, Katsuyuki; Tabata, Masahiro; Toyooka, Shinichi; Maeda, Yoshinobu; Miyahara, Nobuaki
发表日期：2025
文献求助 收藏

Remarkable Efficacy of Capmatinib in a Patient with Cancer of Unknown Primary with MET Amplification

卡马替尼治疗MET扩增型原发灶不明癌症患者疗效显著

期刊:Internal Medicine
影响因子:1.1
doi:10.2169/internalmedicine.5028-24
Tanaka, Takaaki; Makimoto, Go; Sumii, Ryohei; Omote, Rika; Ando, Yayoi; Ninomiya, Kiichiro; Ichihara, Eiki; Ohashi, Kadoaki; Maeda, Yoshinobu; Tabata, Masahiro
肿瘤
MET
肿瘤免疫
发表日期：2025
文献求助 收藏

A Prompt Diagnosis of Ascites and Dramatic Effect of Alectinib for Advanced Lung Adenocarcinoma Harboring EML4-ALK Fusion

对携带 EML4-ALK 融合基因的晚期肺腺癌进行及时诊断，发现腹水并能显著改善其症状，同时阿来替尼也取得了显著疗效。

期刊:Internal Medicine
影响因子:1.1
doi:10.2169/internalmedicine.5397-25
Baba, Takahiro; Inoue, Hirofumi; Matsuoka, Hiromi; Kyakuno, Mio; Yoshinaga, Yusuke; Takeguchi, Tetsuya; Fujiwara, Miho; Yamada, Kotaro; Nakamura, Eri; Morita, Ayako; Hara, Naofumi; Ninomiya, Kiichiro; Higo, Hisao; Fujii, Masanori; Ichihara, Eiki; Rai, Kammei; Ohashi, Kadoaki; Hotta, Katsuyuki; Tabata, Masahiro; Maeda, Yoshinobu; Togashi, Yosuke; Makimoto, Go
ALK
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏